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symptoms of dizziness. More pronounced alexithymic char-
acteristics were associated with lower HRQoL, especially in 
the mental dimension of the SF-12. The results remained sig-
nificant after controlling for possibly confounding variables 
such as socioeconomic status and depression.  Conclusions: 
These findings contribute to a better understanding of affect 
regulation in patients with dizziness, which is important for 
the development of psychotherapeutic interventions suit-
able for alexithymic patients with dizziness. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Alexithymia is a personality trait characterized by def-
icits in regulating, experiencing and verbalizing emo-
tions  [1–3] . Typical features of alexithymia are difficulties 
in identifying and describing feelings, a decreased ability 
to differentiate between emotional states and physical 
sensations, limited imaginative activity, poorer fantasy 
and an externally oriented cognitive style with a lack of 
symbolic thought  [1, 4–6] . These difficulties are believed 
to cause an inability to regulate emotions and to be im-
portant factors in the maintenance and possible etiology 
of physical and mental health problems  [3, 6–10] . Alex-
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 Abstract 
 Background: Alexithymia is a personality trait characterized 
by deficits in regulating, experiencing and verbalizing emo-
tions and has been assumed to be associated with a tenden-
cy to express emotional arousal through somatization. Al-
though such a tendency is often observed in patients with 
dizziness, the exact relationship of alexithymia to dizziness is 
not yet known. The aim of this study was to examine alexithy-
mic characteristics in patients with dizziness and its relation 
to health-related quality of life (HRQoL).  Sampling and Meth-
ods: We assessed 208 patients from an interdisciplin-
ary center for vertigo and balance disorders for character-
istics of alexithymia (20-item Toronto Alexithymia Scale), 
HRQoL (Short-Form 12 Health Survey, SF-12), dizziness (Dizzi-
ness Handicap Inventory), depression and anxiety (Hospital 
Anxiety and Depression Scale). Hierarchical regression analy-
ses were used to evaluate the relationship between alexi-
thymia, dizziness and HRQoL.  Results: We found that difficul-
ties in identifying and describing feelings, two important fac-
tors of alexithymia, were significantly related to more severe 
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ithymic individuals are assumed to focus on somatic sen-
sations that accompany emotional arousal, which leads to 
somatosensory amplification and misinterpretation of 
somatic sensations as signs of physical illness (i.e. soma-
tization or dizziness)  [11] . Furthermore, alexithymic in-
dividuals are not only prone to develop psychosomatic 
disturbances, but also tend to perceive a poorer health-
related quality of life (HRQoL). The association between 
alexithymia and HRQoL has been well examined in the 
general population and alexithymia is presumed to be a 
predisposing factor for poorer HRQoL  [10] . Alexithymia 
has also been found to be negatively associated with life 
satisfaction in primary-care patients after controlling for 
depression and other confounding variables  [12] . How-
ever, there are few studies on this issue in clinical popu-
lations. In patients with chronic pain, alexithymia ap-
peared to play a significant role for low HRQoL  [13] : a 
significant negative correlation was observed between 
HRQoL and alexithymia, assessed with the 20-Item To-
ronto Alexithymia Scale (TAS-20). The TAS-20 subscale 
‘Difficulty Describing Feelings’ was a significant predic-
tor of the psychological domain of HRQoL, even after 
controlling for depression, somatization and gender. 
Similarly, alexithymic characteristics played a role in pre-
dicting the HRQoL in patients with inflammatory bowel 
disease  [14] . 
 Another group of diseases which is associated to poor 
HRQoL comprises dizziness-related disorders  [15] . Diz-
ziness is a common and disabling symptom in primary-
care practice  [16] with a negative impact on HRQoL  [15] . 
As one of the most challenging symptoms in medicine, it 
is difficult to define and diagnose, impossible to measure 
directly and a challenge to treat  [17] . The reported gen-
eral lifetime prevalence of severe dizziness in the German 
population is 29.3% (95% CI 27.8–30.9)  [18] . Various dis-
ease entities may cause dizziness; thus, the reported fre-
quency of specific diagnoses varies widely, depending on 
the setting, age and individual investigator  [17] . Dizziness 
as a syndrome has central-vestibular, peripheral-vestibu-
lar, internal and psychological facets  [19] . About 30% of 
patients with peripheral vestibular dizziness and 70% 
with vestibular migraine develop a secondary somato-
form dizziness syndrome  [20] . Often, it is not easy to 
make a clear distinction between psychological and phys-
ical causation. If somatic disturbances are found, the dis-
comfort may only partially be explained by these find-
ings, and dizziness is often caused or influenced by psy-
chological aspects. Previous studies reported a high 
comorbidity of dizziness, anxiety disorders and depres-
sion  [16, 21, 22] , and 30% of complex dizziness syndromes 
that are insufficiently explained medically are regarded 
as having a somatoform nature  [20] . Therefore, it is im-
portant to develop an explanatory model that includes 
somatic as well as psychological factors. One of these psy-
chological factors could be alexithymia, which has been 
reported to be associated with a tendency to express emo-
tional arousal through somatic symptoms. However, to 
our knowledge, there are no studies on alexithymia in 
patients with dizziness. 
 This study examined alexithymia in a large sample of 
patients with dizziness and evaluated the possible asso-
ciation between HRQoL and alexithymia. In view of the 
previous findings described above, it was hypothesized 
that (1) alexithymic characteristics are significantly re-
lated to dizziness symptoms, and (2) higher alexithy-
mia scores show a significant association to a reduced 
HRQoL, especially in the mental dimension of HRQoL.
 Methods 
 Participants 
 The study was authorized by the ethics committee of the can-
ton of Zurich. All participants gave their written informed con-
sent.
 From August 2009 to April 2010, all patients aged between 18 
and 65 years who were referred to the Interdisciplinary Centre for 
Vertigo and Balance Disorders of the University Hospital Zurich 
were asked to participate in the study. They received question-
naires together with their appointment date by mail, which were 
returned at the clinical examination. If data or consent were miss-
ing, patients were asked to complete the data and submit consent 
to participate. Patients were excluded if questionnaires were in-
complete (more than two missing items) or if no written consent 
was obtained ( fig. 1 ). 
 Measures 
 The TAS-20 (German version) was used to assess alexithymia 
 [23, 24] . The TAS-20 is a reliable and valid self-rating measure of 
the alexithymia construct. Empirically validated, this instrument 
contains the following factors: factor 1 (difficulty identifying feel-
ings, DIF), factor 2 (difficulty describing feelings, DDF) and fac-
tor 3 (externally oriented thinking, EOT). The TAS-20 is the most 
widely used measure of alexithymia and the generalizability of
its 3-factor structure was demonstrated across languages and
cultures, including the German version  [25] . The international 
threshold criterion for alexithymia (TAS-20  6 61) was not used in 
our study as this criterion may not be representative for all popu-
lations, e.g. the German population  [26] .
 The Short-Form 12 Health Survey (SF-12) was used to rate 
HRQoL  [27, 28] . It is a shortened version of the SF-36  [29] and 
measures health in eight dimensions (level of physical function, 
physical role function, physical pain, general experience of health, 
vitality, social functioning, emotional role function and psycho-
logical well-being). Physical and mental health composite scores 
were computed using the scores of the 12 questions. SF-12 dem-
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onstrated good factorial validity in a sample of somatic disease 
 [27] , and relative validity estimated for the mental sum score 
ranged from 0.60 to 1.07 (median = 0.97) in relation to the 36-item 
scale  [28] . The SF-12 reaches 80% of the precision of the well-es-
tablished SF-36, which shows satisfactory reliability (Cronbach’s 
alpha = 0.70), highly satisfactory factorial validity and satisfac-
tory discriminant validity  [29] .
 The Hospital Anxiety and Depression Scale (HADS, German 
version) assesses anxiety and depression  [30, 31] and consists of 
14 items. Each item is rated with 0–3 points. On two subscales 
with 7 items each, the degree of anxiety and depression is mea-
sured on a scale from 0 to 21. Scores from 8–10 indicate a possible, 
and scores  1 10 a probable depression or anxiety disorder  [32] . Al-
though the latent structure of the HADS is unclear, the scale has 
been shown to be an effective measure of emotional distress  [33] . 
An acceptable test-retest reliability for patients with vestibular 
disorder has been reported  [34] . 
 The Dizziness Handicap Inventory (DHI, German version) is 
a disease-specific self-rating questionnaire for the severity of diz-
ziness  [35, 36] . The DHI consists of 25 items and is divided into 3 
subscales (9-item functional subscale, 7-item physical subscale 
and 9-item emotional subscale). It indicates the patient’s self-per-
ceived level of handicap associated with their dizziness on a total 
score (range 0–100) on a 3-step scale (yes = 4 points, sometimes = 
2 points and no = 0 points). The German version of the DHI dem-
onstrated good reliability (test-retest reliability r = 0.92–0.97) and 
internal consistency (  = 0.72–0.89) and is thus recommended as 
a measure of disability in patients with dizziness  [36, 37] . 
 Clinical and sociodemographic characteristics were assessed 
by a questionnaire that was developed in the Interdisciplinary 
Centre for Vertigo and Balance Disorders for clinical use ( table 1 ). 
In this questionnaire, the variables ‘education’ (primary/second-
ary/high school diploma), ‘occupation’ (unskilled worker/skilled 
worker/university degree) and the current employment status 
(currently employed/unemployed) were assessed. To determine 
the socioeconomic status (SES), each of the variables was rated:
0 points each for the lowest items (no secondary school gradua-
tion/unskilled worker/unemployed), 1 point each for the interme-
diate items (secondary school graduation/skilled worker/current-
ly employed) and 2 points each for the highest items (high school 
diploma/university degree). Out of these values, a sum score was 
calculated, which ranged from a minimum of 0 points (‘very low’) 
to 5 points (‘very high’).
Asked for participation
(n = 362)
Returned questionnaires
(n = 303)
Analyzed
(n = 208)
Excluded (n = 95)
declined to participate (n = 39)
questionnaires not completed (n = 56)*
Excluded (n = 59)
questionnaires not returned
 
 Fig. 1. Flowchart of the recruitment and retention of participants 
in the trial.  *  TAS-20 or major parts of the other questionnaires 
not completed (more than 2 items missing). 
Table 1. D emographic and clinical characteristics of 208 patients 
with dizziness
Age, years 45.2811.8
Duration of dizziness, weeks 188.58277.5
Frequency of dizziness, times/week 5.382.2
HADS
Depression 5.484.1
Anxiety 6.886.8
SF-12
MCS 45.6810.9
PCS 40.3810.9
DHI
Total sum score 42.3823.5
Physical scale 13.087.5
Emotional scale 13.188.4
Functional scale 16.2810.5
SES (min = 0, max = 5) 3.281.3
Gender, female/male 97/111 (46.6/53.4)
Characteristics of dizzinessa
Acute 56 (26.9)
Chronic 145 (69.7)
Permanent 48 (23.1)
Attacks 119 (57.2)
Educational level
No secondary school graduation 10 (4.8)
Secondary school graduation 121 (58.2)
High school diploma 70 (33.7)
Occupation
Unskilled worker 14 (6.7)
Skilled worker 124 (59.6)
University degree 55 (26.4)
Employment status
Currently employed 145 (69.7)
Unemployed 57 (27.4)
R esults are presented as means 8 SD or numbers with per-
centages in parentheses.
a Multiple responses.
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 Statistics 
 To assess gender differences, the   2 test was used for nominal 
variables and the Student t test for continuous variables. The Pear-
son correlations were calculated to evaluate possible associations 
between the TAS-20, SF-12, DHI and other variables. To avoid
accumulation of the   -error, Bonferroni adjustments were per-
formed to evaluate 16 correlations between the TAS-20 and the 
DHI as well as the 8 correlations between the TAS-20 and the SF-
12  [38] .
 Hierarchical regression analyses were carried out to test the 
influence of the TAS-20 and its subfactors on the HRQoL. The 
two SF-12 subscales mental health component summary score 
(MCS) and physical component summary score (PCS) served as 
dependent variables. Because of the previously reported associa-
tion of alexithymia with depression, gender and SES, these vari-
ables were entered simultaneously in step 1 of the regression equa-
tion. As we found no bivariate association between age and the 
TAS-20 in our sample, ‘age’ was not included. In a second step, the 
TAS-20 total score and the three subfactors DDF, DIF and EOT, 
respectively, were included in the analysis.
 In the regression analyses, tolerance of all predictors was 
 6 0.46, indicating low multicollinearity  [39] . Furthermore, it was 
tested if the residuals showed a normal distribution. All regres-
sion residuals were normally distributed (Kolmogorov-Smirnov-
test, p  1 0.25).
 The Statistical Package for Social Sciences (SPSS; Version 19.0) 
was used for all calculations. 
 Results 
 Clinical and Demographic Characteristics 
 Of the 362 patients who were asked to participate, 208 
(58%) gave their written informed consent, completed the 
questionnaires ( fig. 1 ) and were included in the study. The 
mean age was 45.2 years, 97 of the patients (47%) were 
women ( table 1 ). Women showed a significantly longer 
duration of dizziness than men (t = 2.12, d.f. = 148, p = 
0.04). The SES of men was higher (mean 3.3, SD 1.26) 
than that of women (mean 2.9, SD 1.22; t = 2.36, d.f. = 
200, p = 0.02).
 The mean TAS-20 total score was 42.1 ( table 2 ). We 
found no significant correlations between the TAS-20 
and age, neither for the total score nor for the subfactor 
scores. The TAS-20 total score correlated significantly 
with the HADS depression score (r = 0.56, p  ! 0.001).
 Relationship between Alexithymia and Dizziness 
 We found significant positive correlations between the 
TAS-20 total score and the DHI total score (r = 0.30, p  ! 
0.001) as well as the emotional and functional scale scores 
( table  3 ). Regarding the TAS-20 subfactors, there were 
Table 2. T AS-20 scores for 208 patients with dizziness
Total
mean 8 SD
Women
mean 8 SD
Men
mean 8 SD
t test
t d.f. p
TAS-20 total score 42.1811.3 40.1811.3 43.8811.0 –2.38 206 0.018
Factor 1: ‘DIF’ 13.585.8 12.485.5 14.486.0 –2.45 206 0.015
Factor 2: ‘DDF’ 10.283.8 9.483.9 10.983.6 –2.91 206 0.004
Factor 3: ‘EOT’ 18.484.4 18.384.7 18.684.2 –0.47 205 0.638
Table 3. B ivariate correlations between the TAS-20, SF-12 and DHI for 208 patients with dizziness
SF-12 
MCS
SF-12 
PCS
DHI 
total
DHI 
phys.
DHI 
emot.
DHI 
funct.
TAS-20 
total score
DIF DDF
TAS-20 total score –0.46c –0.17 0.30c 0.18 0.38c 0.25b
DIF –0.51c –0.20a 0.29c 0.14 0.40c 0.23a 0.86c
DDF –0.42c –0.18 0.29c 0.19 0.33c 0.26b 0.84c 0.67c
EOT –0.12 –0.01 0.13 0.09 0.17 0.09 0.68c 0.30c 0.39c
D HI emot. = DHI emotional scale; DHI funct. = DHI functional scale; DHI phys. = DHI physical scale; DHI 
total = DHI total sum score.
a p < 0.05; b p < 0.01; c p < 0.001 Pearson correlations (Bonferroni-corrected p values for correlations between 
TAS-20 and SF-12 as well as DHI).
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significant positive correlations between factor 1 (DIF) 
and factor 2 (DDF) with the DHI total score as well as the 
emotional and functional scale scores, whereas factor 3 
(EOT) did not correlate with the DHI total and subscale 
scores ( table 3 ). 
 Alexithymia and HRQoL 
 Significantly lower values in the MCS (45.6) and PCS 
(40.3) were obtained in our sample compared to the Ger-
man general population in the questionnaire’s manual 
(MCS 52.2, p  ! 0.001; PCS 49.0, p  ! 0.001) and a mixed 
population of patients with chronic disease (MCS 51.2,
p  ! 0.001; PCS 46.3, p  ! 0.001)  [29] .
 In the bivariate correlational analysis, the TAS-20 total 
sum score and the subfactors DIF and DDF were nega-
tively correlated with both the MCS of the SF-12 and – to 
a lesser extent – with the PCS ( table 3 ). 
 In the hierarchical regression analyses, the TAS-20 to-
tal score added significantly to the variance of the MCS 
explained by the 3 control variables, i.e. gender, SES and 
depression score. Entering the TAS-20 subfactors to the 
regression analysis after the control variables resulted in 
a significant increase of variance explanation, primarily 
attributable to the DIF. HADS depression score was also 
a significant predictor of the MCS ( table 4 ). 
 In the hierarchical regression analyses regarding the 
PCS, neither the TAS-20 total score nor the TAS-20 sub-
factors explained significantly more variance than the 
control variables. HADS depression was a significant 
predictor of the PCS ( table 4 ).
 Discussion 
 To the best of our knowledge, this is the first study on 
alexithymic characteristics in patients with dizziness. As 
a main result, we found that difficulties in identifying 
and describing feelings, two important facets of alexi-
thymia, were significantly related to more severe dizzi-
ness. We also found that more pronounced alexithymic 
characteristics were related to a lower HRQoL, especially 
in the mental dimension of the SF-12. Both results were 
in accordance with our study hypotheses.
 When interpreting these findings, a number of study 
limitations should be taken into consideration. First, the 
data were collected via questionnaires, this despite the 
fact that alexithymic patients may have difficulty in ac-
curately rating their deficits. According to Taylor et al. 
 [3] , clinicians should use the TAS-20 as a screening device 
for alexithymia and evaluate the significance of an indi-
Table 4. R egression analysis for HRQoL as a dependent variable and gender, depression, socioeconomic status 
and alexithymia as predictive variables
SF-12 MCS S F-12 PCS
adjusted R2 R2 pb c pd adjuste d R2 R2 pb c pd
Step 1a 0.48 0.49 <0.001 0.18 0.19 <0.001
Step 2 0.49 0.01 0.04 0.19 0.01 0.14
Gender 0.05 0.33 0.10 0.15
HADS D –0.66 <0.001 –0.45 <0.001
SES –0.09 0.10 0.11 0.10
TAS-20 total –0.13 0.04 0.12 0.14
Step 1a 0.48 0.48 <0.001 0.18 0.19 <0.001
Step 2 0.50 0.03 0.02 0.18 0.01 0.37
Gender 0.06 0.28 0.10 0.14
HADS D –0.62 <0.001 –0.43 <0.001
SES –0.09 0.12 0.12 0.10
DIF –0.17 0.02 0.02 0.88
DDF –0.05 0.46 0.03 0.79
EOT 0.07 0.20 0.11 0.13
HAD S D = HADS depression score.
a Variables: gender, HADS D and SES; b significance level of R2; c standardized coefficient; d significance 
level of coefficients.
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vidual patient’s score in the context of information de-
rived from other sources including clinical observations, 
reports from close friends or relatives of the patient and 
results from other personality tests  [3] . In future studies, 
the Toronto Structured Interview for Alexithymia  [40] , 
with its prompts and probes to elicit further information 
and to appraise and judge such deficits, may help to over-
come such specific problems in self-report measurements 
for assessing alexithymia. The original version and the 
German version of this structured interview demonstrate 
adequate item characteristics, a significant correlation 
with the TAS-20, and adequate interrater, internal and 
retest reliability  [40, 41] . Second, we cannot exclude a se-
lection bias as all patients were recruited from a special-
ized dizziness unit, and 95 patients declined to give writ-
ten consent or failed to complete the questionnaires. As 
we found relatively low mean values of the TAS-20 in our 
sample (comparable to healthy controls and relatives of 
patients with obsessive-compulsive disorder  [42] ), pa-
tients with more pronounced alexithymic characteristics 
may have had more difficulty filling in the TAS-20 and/
or may have more often declined to participate. Third, 
due to the cross-sectional design of our study, we cannot 
determine causality. There is a need for prospective lon-
gitudinal studies for a better characterization of the pos-
sible impact of alexithymia on dizziness and HRQoL.
 However, despite these limitations, our study does 
suggest that there is a significant link between alexi-
thymia and dizziness. It is well known that an underlying 
organic cause is not found in approximately 30% of diz-
ziness syndromes and that they are often psychosomatic 
in nature or related to a psychiatric disorder  [20] . The re-
sults of our study are in accordance with the view that 
individuals with difficulties in identifying and describ-
ing feelings may be prone to experience psychological 
distress in the form of somatic symptoms rather than as 
emotions, e.g. medically unexplained somatic symptoms 
or psychosomatic diseases  [11] . In earlier studies, difficul-
ties in identifying and/or describing feelings have been 
particularly associated with somatization independently 
of somatic diseases, somatoform disorders  [43–45] , de-
pression, anxiety  [46] as well as the increased utilization 
of health care [47] . Furthermore, high scores in difficul-
ties in identifying feelings emerged as an important pre-
dictor for somatization, as measured by the SCL-90-R 
 [44] . The association between the characteristics of alex-
ithymia and the HRQoL is consistent with results of pre-
vious studies on the relationship between alexithymia 
and the HRQoL in the general population  [10] , in prima-
ry care  [12] as well as in patients with chronic pain  [13] , 
inflammatory bowel disease  [14] , ulcerative colitis and 
Crohn’s disease  [48] , coronary heart disease  [49] or breast 
cancer  [50] , all of which determined a negative correla-
tion between HRQoL and alexithymia independent of so-
ciodemographic and psychopathological factors like de-
pression. 
 Our findings of a significant relationship between alex-
ithymia, HRQoL and dizziness suggest that assessing 
alexithymia in patients with dizziness at the onset of ther-
apy may be helpful for individualized therapy planning. 
Some previous studies have reported that alexithymic pa-
tients are less responsive to psychotherapy than nonalex-
ithymic patients  [2] . Suitable psychotherapeutic interven-
tion approaches for patients with dizziness as well as their 
difficulties in identifying and describing their feelings 
have been discussed in the literature  [51] . Specific cogni-
tive-behavioral therapy for chronic dizziness includes an 
integrative explanation model for dizziness with medical 
and psychological factors  [52] . Interoceptive exposure to 
dizziness symptoms is a core element of cognitive-behav-
ioral therapy CBT in patients with dizziness, as well as 
relaxation techniques, physical exercise and physiothera-
py  [53–55] . However, in patients with high levels of alexi-
thymia, the aims of psychotherapy should also include im-
provements in the awareness of feelings, thoughts and fan-
tasies to facilitate the regulation of emotional arousal. 
Furthermore, an improved ability to regulate their emo-
tions may help patients with dizziness to cope effectively 
with stressful events in their daily life  [56] . Thus, it may be 
possible for alexithymic patients with dizziness to reduce 
their dizziness symptoms and to improve their HRQoL.
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